Robotic seeds brachytherapy for superior treatment outcomes in prostate cancer


As a treatment modality to treat prostate cancer, Seeds brachytherapy has gained wide acceptance due to its minimal invasive nature combined with excellent treatment results. However, prostate cancer patient outcomes of Seed implants continue to be dependent on the manual delivery of the dose... Nucletron offers a unique brachytherapy system that enables robotic brachytherapy for prostate cancer to take much of the manual dependency risk away, resulting in superior treatment outcomes.


Robotic Brachytherapy

When a prostate cancer patient is treated with the Nucletron FIRST system, the radioactive seeds are delivered into the prostate using a robotic brachytherapy system that places the seeds with unmatched accuracy and flexibility. With this increased accuracy in seeds placement, the dose can be focused precisely on the prostate while the dose to the surrounding healthy tissue can be greatly minimized.


Superior treatment outcomes

Prostate cancer patients that are eligible for Seeds brachytherapy are usually low-risk patients. Due to the low-risk nature of the disease, local recurrence of the disease is rare. Therefore, minimizing side effects is an important issue for these prostate cancer patients.


With the Nucletron brachytherapy FIRST system for prostate cancer treatment, dose coverage is better compared to seeds treatment with non-robotic implant of stranded seeds.

For more on FIRST or other brachytherapy solutions for prostate cancer, please click here or contact us